BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25494861)

  • 1. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers.
    Kaemmerer D; Specht E; Sänger J; Wirtz RM; Sayeg M; Schulz S; Lupp A
    J Clin Endocrinol Metab; 2015 Mar; 100(3):831-40. PubMed ID: 25494861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms.
    Specht E; Kaemmerer D; Sänger J; Wirtz RM; Schulz S; Lupp A
    Histopathology; 2015 Sep; 67(3):368-77. PubMed ID: 25641082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
    Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
    Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
    Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
    Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
    Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
    Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors.
    Galván JA; Astudillo A; Vallina A; Crespo G; Folgueras MV; González MV
    BMC Cancer; 2014 Nov; 14():855. PubMed ID: 25413006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
    Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
    Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.
    Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A
    Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
    Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
    Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
    Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
    Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary neuroendocrine neoplasms].
    Sayeg Y; Sayeg M; Baum RP; Kulkarni HR; Presselt N; Mäder I; Kunze A; Sänger J; Hörsch D; Bonnet R
    Pneumologie; 2014 Jul; 68(7):456-77. PubMed ID: 25006841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
    Yeh YC; Chou TY
    J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
    Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the expression of somatostatin receptors by immunohistochemistry in neuroendocrine tumors of the small intestine.
    Pol J Pathol; 2020; 71(1):30-37. PubMed ID: 32429652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of neuroendocrine lung tumors.
    Sánchez de Cos Escuín J
    Arch Bronconeumol; 2014 Sep; 50(9):392-6. PubMed ID: 24685201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.
    Slaby O; Sachlova M; Bednarikova M; Fabian P; Svoboda M; Vytopilova S; Valik D; Vyzula R
    Cancer Biother Radiopharm; 2010 Apr; 25(2):237-43. PubMed ID: 20423238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
    Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
    Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.